| The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance N Loret, H Denys, P Tummers, G Berx Cancers 11 (6), 838, 2019 | 233 | 2019 |
| Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience LA Groen, P Hoebeke, N Loret, C Van Praet, E Van Laecke, R Ann, ... The Journal of urology 188 (4), 1313-1318, 2012 | 78 | 2012 |
| ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition N Skrypek, K Bruneel, C Vandewalle, E De Smedt, B Soen, N Loret, ... Epigenetics & Chromatin 11, 1-15, 2018 | 18 | 2018 |
| Distinct transcriptional programs in ascitic and solid cancer cells induce different responses to chemotherapy in high-grade serous ovarian cancer N Loret, N Vandamme, J De Coninck, J Taminau, K De Clercq, G Blancke, ... Molecular Cancer Research 20 (10), 1532-1547, 2022 | 8 | 2022 |
| The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance. Cancers (Basel) 11: 1–22 N Loret, H Denys, P Tummers, G Berx | 5 | 2019 |
| Application of sacral and pudendal nerve stimulation in children N Loret Dissertation for Master of Medicine in Medicine. Universiteit Gent, Belgium …, 2015 | 1 | 2015 |
| ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states J Verstappe, N Skrypek, J De Coninck, B Soen, J Taminau, M Tatari, ... iScience 27 (11), 2024 | | 2024 |
| Cellular plasticity and heterogeneity in ovarian cancer progression and therapy resistance N Loret Ghent University, 2021 | | 2021 |
